Vertex Pharmaceuticals (VRTX) had the worst year in 2003 by a US stock in the S&P 500 (GSPC) in 2003, returning -35.4%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Vertex Pharmaceuticals (VRTX) | 2003 | -35.43% |
Regeneron Pharmaceuticals (REGN) | 2003 | -20.7% |
EMCOR (EME) | 2003 | -17.2% |
Mondelez International (MDLZ) | 2003 | -15.95% |
Merck (MRK) | 2003 | -12.69% |
Charles River Laboratories (CRL) | 2003 | -11.06% |
DTE Energy (DTE) | 2003 | -10.65% |
Lockheed Martin (LMT) | 2003 | -10.41% |
CMS Energy (CMS) | 2003 | -10.03% |
Mosaic (MOS) | 2003 | -7.51% |
WW Grainger (GWW) | 2003 | -6.88% |
STERIS (STE) | 2003 | -6.8% |
Verizon Communications (VZ) | 2003 | -6.64% |
Avery Dennison (AVY) | 2003 | -6.5% |
Nasdaq (NDAQ) | 2003 | -5.59% |
Colgate-Palmolive (CL) | 2003 | -3.15% |
Johnson & Johnson (JNJ) | 2003 | -3.05% |
General Mills (GIS) | 2003 | -1.2% |
Skyworks Solutions (SWKS) | 2003 | -0.91% |
Baker Hughes (BKR) | 2003 | -0.1% |
Northrop Grumman (NOC) | 2003 | 0.31% |
AT&T (T) | 2003 | 0.62% |
Brown & Brown (BRO) | 2003 | 1.12% |
International Flavors & Fragrances (IFF) | 2003 | 1.14% |
CoreSite Realty (COR) | 2003 | 1.8% |